Discontinuation report APO-VALPROIC ACID ORAL SOLUTION
Report ID | 205310 |
Drug Identification Number | 02238370 |
Brand name | APO-VALPROIC ACID ORAL SOLUTION |
Common or Proper name | VALPROIC ACID |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | VALPROIC ACID |
Strength(s) | 250MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | 450 mL |
ATC code | N03AG |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2023-11-01 |
Remaining supply date | 2023-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-11-02 | English | Compare |
v2 | 2023-09-26 | French | Compare |
v1 | 2023-09-26 | English | Compare |
Showing 1 to 3 of 3